A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Cheng ^a   Hu, Jicheng ^b   Lu, Meiling ^a   Gu, Hongwei ^a   Zhou, Xiaojun ^a   Chen, Xi ^a   Zen, Ke ^a   Zhang, Chen Yu ^a   Zhang, Tiehui ^b   Ge, Jingping ^a   Wang, Junjun ^a   Zhang, Chunni ^a  

^a NANJING UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; BLOOD; CANCER STAGING; CARCINOMA, RENAL CELL; CASE CONTROL STUDY; EARLY DIAGNOSIS; FEMALE; GENETICS; HUMAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AREA UNDER CURVE; BIOMARKERS, TUMOR; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84929626945     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07610     Document Type: Article

References (38)

1. Eble, J. N., Togashi, K., Pisani, P. [Renal cell carcinoma] Pathology & Genetics: Tumors of the urinary system and male genital organs. [Eble, J. N., Sauter, G., Epstein, J. I., Sesterhen, I. A. (ed.)] [1-87] (IARC, Lyon, 2004).
2. Rini, B. I., Campbell, S. C., Escudier, B. Renal cell carcinoma. Lancet 373, 1119-1132 (2009).
3. Gottardo, F. et al.MicroRNA profiling in kidney and bladder cancers. Urol Oncol 25, 387-392 (2007).
4. Siegel, R., Naishadham, D., Jemal, A. Cancer statistics. CA Cancer J Clin 62, 10-29 (2012).
5. Banumathy, G., Cairns, P. Signaling pathways in renal cell carcinoma. Cancer Biol Ther 10, 658-664 (2010).
6. Ljungberg, B. et al. European Association of Urology Guideline Group EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58, 398-406 (2010).
7. Weng, L. et al. MicroRNA profiling of clear cell renal cell carcinoma by wholegenome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol 222, 41-51 (2010).
8. Schaefer, A., Stephan, C., Busch, J., Yousef, G. M., Jung, K. Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat Rev Urol 7, 286-297 (2010).
9. Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18, 997-1006 (2008).
10. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105, 10513-10518 (2008).
11. Zhang, C. et al. Expression profile of microRNAs in serum: A fingerprint for esophageal squamous cell carcinoma. Clin Chem 56, 1871-1879 (2010).
12. Liu, R. et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 58, 610-618 (2012).
13. Wulfken, L. M. et al.MicroRNAs in renal cell carcinoma: Diagnostic implications of serum miR-1233 levels. PLoS One 6, e25787 (2011).
14. Redova, M. et al. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med 10, 1-8 (2012).
15. Hauser, S. et al. Analysis of serum microRNAs (miR-26a-2, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma. Cancer Epidemiol 36, 391-394 (2012).
16. Zhai, Q. et al. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. Biochem Biophys Res Commun 419, 621-626 (2012).
17. Zhao, A., Li, G., Peóc'h, M., Genin, C., Giqante, M. Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp Mol Pathol 94, 115-120 (2013).
18. Cheng, T. et al. Differential microRNA expression in renal cell carcinoma. Oncol Lett 6, 769-776 (2013).
19. Teixeira, A. L. et al. Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients. Tumour Biol 35, 4057-4066 (2014).
20. Iwamoto, H. et al. Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma. Int J Oncol 44, 53-58 (2014).
21. Pu, X. X. et al. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 25, 1674-1680 (2010).
22. Song, M. Y. et al. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One 7, e33608 (2012).
23. Li, Z. H. et al. Prognostic significance of serum microRNA-210 levels in nonsmallcell lung cancer. J Int Med Res 41, 1437-1444 (2013).
24. Cheng, H. H. et al. Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia. PLoS One 8, e69239 (2013).
25. Wu, C. et al. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma. PLoS One 9, e92292 (2014).
26. Zanutto, S. et al. Circulating miR-378 in plasma: a reliable, haemolysisindependent biomarker for colorectal cancer. Br J Cancer 110, 1001-1007 (2014).
27. Liu, H. et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 316, 196-203 (2012).
28. Liu, X. et al.Diagnostic and prognostic value of plasmamicroRNAderegulation in nasopharyngeal carcinoma. Cancer Biol Ther 14, 1133-1142 (2013).
29. Chen, X. et al. A combination of let-7d, let-7g and let-7i serves as a stable reference for normalization of serum microRNAs. PLoS One 8, 1-12 (2013).
30. Zhang, G. J., Zhou, H., Xiao, H. X., Li, Y., Zhou, T. MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer. BMC Cancer 214, 1-9 (2014).
31. Fei, B.,Wu, H. MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro. Oncol Res 220, 557-564 (2012).
32. Yu, B. L. et al. MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression. Int J Oncol 44, 1215-1222 (2014).
33. Chan, J. K. et al. MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer. Gynecol Oncol 133, 568-574 (2014).
34. Xia, J. T. et al. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-kB signaling. J Transl Med 12, 1-12 (2014).
35. Benjamin, H. et al. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn 12, 771-779 (2010).
36. Almeida, M. I. et al. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 142, 886-896 (2012).
37. Li, Z., Gu, X., Fang, Y., Xiang, J., Chen, Z. microRNA expression profiles in human colorectal cancers with brain metastases. Oncol Lett 3, 346-350 (2012).
38. Luo, Y. et al. Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin Chem 59, 658-666 (2013).